MSN Laboratories initiates phase-III trial of Molnupiravir

Clinical trials will be performed on more than 2,400 subjects suffering from mild-to-moderate Covid-19

Comments

Popular posts from this blog

‘No difference between Congress, PFI’: Karnataka BJP

2 Mangaluru businessmen in Saudi to fly 167 home